Elf5, hormones and cell fate

Trends in Endocrinology and Metabolism

Volumn 23, Issue 6, 2012, Pages 292-298

  Lee, Heather J ^a,b   Ormandy, Christopher J ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; ELF5 PROTEIN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GROWTH HORMONE; HORMONE; NUCLEIC ACID BINDING PROTEIN; PROGESTERONE RECEPTOR; PROLACTIN; PROLACTIN RECEPTOR; STAT5 PROTEIN; STAT5A PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BREAST CELL; BREAST DEVELOPMENT; CELL DIVISION; CELL FATE; CELL POPULATION; DISEASE COURSE; HUMAN; MAMMARY GLAND; METHYLATION; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; FEMALE; HORMONES; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MODELS, ANIMAL; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTORS;

EID: 84861683145     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.02.006     Document Type: Review

References (69)

1. Reid B.J., et al. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat. Rev. Cancer 2010, 10:87-101.
2. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
3. Klymkowsky M.W., Savagner P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am. J. Pathol. 2009, 174:1588-1593.
4. Zhou J., et al. A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13-15, a region subject to LOH and rearrangement in human carcinoma cell lines. Oncogene 1998, 17:2719-2732.
5. Choi Y.S., Sinha S. Determination of the consensus DNA-binding sequence and a transcriptional activation domain for ESE-2. Biochem. J. 2006, 398:497-507.
6. Choi Y.S., et al. Generation and analysis of Elf5-LacZ mouse: unique and dynamic expression of Elf5 (ESE-2) in the inner root sheath of cycling hair follicles. Histochem. Cell Biol. 2008, 129:85-94.
7. Lapinskas E.J., et al. A major site of expression of the ets transcription factor Elf5 is epithelia of exocrine glands. Histochem. Cell Biol. 2004, 122:521-526.
8. Lapinskas E.J., et al. The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney. Twin Res. Hum. Genet. 2011, 14:316-322.
9. Oettgen P., et al. Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes. J. Biol. Chem. 1999, 274:29439-29452.
10. Parikh N., et al. Isolation and characterization of an immortalized oral keratinocyte cell line of mouse origin. Arch. Oral Biol. 2008, 53:1091-1100.
11. Tummala R., Sinha S. Differentiation-specific transcriptional regulation of the ESE-2 gene by a novel keratinocyte-restricted factor. J. Cell. Biochem. 2006, 97:766-781.
12. Xie B.X., et al. Analysis of differentially expressed genes in LNCaP prostate cancer progression model. J. Androl. 2011, 32:170-182.
13. Nishioka N., et al. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev. Cell 2009, 16:398-410.
14. Rossant J., Tam P.P. Blastocyst lineage formation, early embryonic asymmetries and axis patterning in the mouse. Development 2009, 136:701-713.
15. Sasaki H. Mechanisms of trophectoderm fate specification in preimplantation mouse development. Dev. Growth Differ. 2010, 52:263-273.
16. Roper S., Hemberger M. Defining pathways that enforce cell lineage specification in early development and stem cells. Cell Cycle 2009, 8:1515-1525.
17. Donnison M., et al. Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning. Development 2005, 132:2299-2308.
18. Zhou J., et al. Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. EMBO J. 2005, 24:635-644.
19. Niwa H., et al. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 2005, 123:917-929.
20. Gasperowicz M., Natale D.R. Establishing three blastocyst lineages - then what?. Biol. Reprod. 2011, 84:621-630.
21. Ng R.K., et al. Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5. Nat. Cell Biol. 2008, 10:1280-1290.
22. Hemberger M., et al. Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal. Nat. Rev. Mol. Cell Biol. 2009, 10:526-537.
23. Pearton D.J., et al. Elf5 regulation in the Trophectoderm. Dev. Biol. 2011, 360:343-350.
24. Lee H.J., et al. Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. Stem Cells 2011, 29:1611-1619.
25. Gao Y., et al. Epigenetic regulation of gene expression in porcine epiblast, hypoblast, trophectoderm and epiblast-derived neural progenitor cells. Epigenetics 2011, 6:1149-1161.
26. Hemberger M., et al. ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta. Hum. Mol. Genet. 2010, 19:2456-2467.
27. Robinson G.W. Cooperation of signalling pathways in embryonic mammary gland development. Nat. Rev. Genet. 2007, 8:963-972.
28. Howard B., Ashworth A. Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet. 2006, 2:e112.
29. Van Keymeulen A., et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189-193.
30. Mallepell S., et al. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2196-2201.
31. Feng Y., et al. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14718-14723.
32. Kelly P.A., et al. The role of prolactin and growth hormone in mammary gland development. Mol. Cell. Endocrinol. 2002, 197:127-131.
33. Asselin-Labat M.L., et al. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465:798-802.
34. Schramek D., et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 2010, 468:98-102.
35. Joshi P.A., et al. Progesterone induces adult mammary stem cell expansion. Nature 2010, 465:803-807.
36. Atwood C.S., et al. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J. Endocrinol. 2000, 167:39-52.
37. Ormandy C.J., et al. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 1997, 11:167-178.
38. Brisken C., et al. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:5076-5081.
39. Clevenger C.V., et al. The role of prolactin in mammary carcinoma. Endocr. Rev. 2003, 24:1-27.
40. Yager J.D., Davidson N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 2006, 354:270-282.
41. Harris J., et al. Socs2 and Elf5 mediate prolactin-induced mammary gland development. Mol. Endocrinol. 2006, 20:1177-1187.
42. Choi Y.S., et al. Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. Dev. Biol. 2009, 329:227-241.
43. Menzies K.K., et al. Insulin, a key regulator of hormone responsive milk protein synthesis during lactogenesis in murine mammary explants. Funct. Integr. Genomics 2010, 10:87-95.
44. Menzies K.K., et al. Insulin regulates milk protein synthesis at multiple levels in the bovine mammary gland. Funct. Integr. Genomics 2009, 9:197-217.
45. Hilton H.N., et al. The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5. Mol. Endocrinol. 2010, 24:1380-1392.
46. Ormandy C.J., et al. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J. Clin. Endocrinol. Metab. 1997, 82:3692-3699.
47. Fernandez-Valdivia R., et al. Transcriptional response of the murine mammary gland to acute progesterone exposure. Endocrinology 2008, 149:6236-6250.
48. Oakes S.R., et al. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev. 2008, 22:581-586.
49. Thomas R.S., et al. The Elf group of Ets-related transcription factors. ELF3 and ELF5. Adv. Exp. Med. Biol. 2000, 480:123-128.
50. +/- mammary glands during pregnancy identifies novel targets of Elf5. PLoS ONE 2010, 5:e13150.
51. Yamaji D., et al. Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev. 2009, 23:2382-2387.
52. Kendrick H., et al. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 2008, 9:591.
53. Lim E., et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 2010, 12:R21.
54. Furth P.A., et al. Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer. Breast Cancer Res. 2011, 13:220.
55. Oakes S.R., et al. The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Res. 2006, 8:207.
56. Perou C.M., et al. Clinical implementation of the intrinsic subtypes of breast cancer. Lancet Oncol. 2010, 11:718-719. author reply 720-711.
57. Visvader J.E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 2009, 23:2563-2577.
58. Prat A., et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010, 12:R68.
59. Lim E., et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 2009, 15:907-913.
60. Feldman R.J., et al. The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis. Anticancer Res. 2003, 23:2125-2131.
61. Galang C.K., et al. Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J. Biol. Chem. 2004, 279:11281-11292.
62. He J., et al. Profile of Ets gene expression in human breast carcinoma. Cancer Biol. Ther. 2007, 6:76-82.
63. Escamilla-Hernandez R., et al. Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. BMC Mol. Biol. 2010, 11:68.
64. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 2009, 8:235-253.
65. Weinstein M., et al. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 1998, 125:3615-3623.
66. Ohuchi H., et al. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem. Biophys. Res. Commun. 2000, 277:643-649.
67. Metzger D.E., et al. Elf5 is an epithelium-specific, fibroblast growth factor-sensitive transcription factor in the embryonic lung. Dev. Dyn. 2007, 236:1175-1192.
68. Yaniw D., Hu J. Epithelium-specific ets transcription factor 2 upregulates cytokeratin 18 expression in pulmonary epithelial cells through an interaction with cytokeratin 18 intron 1. Cell Res. 2005, 15:423-429.
69. Metzger D.E., et al. Misexpression of ELF5 disrupts lung branching and inhibits epithelial differentiation. Dev. Biol. 2008, 320:149-160.